CD40 expression on human pancreatic duct cells: Role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines

Diabetologia

Volumn 47, Issue 4, 2004, Pages 660-668

  Vosters, O ^a,b   Beuneu, C ^a,b   Nagy, N ^c   Movahedi, B ^b,d   Aksoy, E ^a   Salmon, I ^c   Pipeleers, D ^b,d   Goldman, M ^a,b   Verhasselt, V ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b JDRF Center for Beta Cell Therapy in Diabetes   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d DIABETES RESEARCH CENTER   (Belgium)

Author keywords

Capan 2; CD40; IL 1 ; Islet transplantation; NF B; Pancreatic duct cells; TNF ; Type 1 diabetes mellitus

Indexed keywords

CD40 LIGAND; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST CULTURE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DUCT; PANCREAS DUCT CELL; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD40; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; NF-KAPPA B; PANCREATIC DUCTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 2442641694     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1363-1     Document Type: Article

References (56)

1. Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633
2. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715-1720
3. Pavlovic D, Winkel M van de, Auwera B van der et al. (1997) Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab 82:2329-2336
4. Pavlovic D, Chen MC, Bouwens L, Eizirik DL, Pipeleers D (1999) Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 48:29-33
5. Bonner-Weir S, Taneja M, Weir GC et al. (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999-8004
6. Bogdani M, Lefebvre V, Buelens N et al. (2003) Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors. Diabetologia 46:830-838
7. Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T (2003) Characterisation of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52:2007-2015
8. Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z (2001) Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 50 [Suppl 1]:S52-S57
9. Ling Z, Pipeleers DG (1996) Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805-2812
10. Keymeulen B, Ling Z, Gorus FK et al. (1998) Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459
11. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
12. Vives-Pi M, Somoza N, Fernandez-Alvarez J et al. (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133:208-218
13. Woltman AM, Haij S de, Boonstra JG, Gobin SJ, Daha MR, Kooten C van (2000) Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 11:2044-2055
14. Propst SM, Denson R, Rothstein E, Estell K, Schwiebert LM (2000) Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J Immunol 165:2214-2221
15. Afford SC, Ahmed-Choudhury J, Randhawa S et al. (2001) CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signalling in human intrahepatic biliary epithelial cells. FASEB J 15:2345-2354
16. Propst SM, Estell K, Schwiebert LM (2002) CD40-mediated activation of NF-kappa B in airway epithelial cells. J Biol Chem 277:37054-37063
17. Haij S de, Woltman AM, Bakker AC, Daha MR, Kooten C van (2002) Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol 2002 137:197-204
18. Amsellem C, Durieu, Chambe MT, Peyrol S, Pacheco Y (2002) In vitro expression of fas and CD40 and induction of apoptosis in human cystic fibrosis airway epithelial cells. Respir Med 96:244-249
19. Berberich I, Shu GL, Clark EA (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol 153:4357-4366
20. Kooten C van, Banchereau J (1997) Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330-337
21. Kooten C van, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2-17
22. Henn V, Slupsky JR, Grafe M et al. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
23. Freedman JE (2003) CD40 ligand - assessing risk instead of damage? N Engl J Med 348:1163-1165
24. Heeschen C, Dimmeler S, Hamm CW et al. (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111
25. Caux C, Massacrier C, Vanbervliet B et al. (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272
26. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135
27. O'Sullivan BJ, Thomas R (2002) CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB. J Immunol 168:5491-5498
28. Homann D, Jahreis A, Wolfe T et al. (2002) CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403-415
29. Moore WV, Chu W, Tong PY et al. (2002) Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade. J Autoimmun 19:139-145
30. De Breuck S, Lardon J, Rooman I, Bouwens L (2003) Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells. Diabetologia 46:926-933
31. Aksoy E, Amraoui Z, Goriely S, Goldman M, Willems F (2002) Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells. Eur J Immunol 32:3040-3049
32. Osborn L, Kunkel S, Nabel GJ (1989) Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 86:2336-2340
33. Stordeur P, Zhou L, Goldman M (2002) Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods 261:195-197
34. Stordeur P, Zhou L, Byl B et al. (2003) Immune monitoring in whole blood using real-time PCR. J Immunol Methods 276:69-77
35. May MJ, Ghosh S (1997) Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 8:63-73
36. Lee JI, Burckart GJ (1998) Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38:981-993
37. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734
38. Corbett JA, McDaniel ML (1995) Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568
39. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA (1998) IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102:516-526
40. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG (2000) Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340-345
41. Hoorens A, Stange G, Pavlovic D, Pipeleers D (2001) Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes 50:551-557
42. Thomas HE, Darwiche R, Corbett JA, Kay TW (2002) Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 51:311-316
43. Tabatabaie T, Vasquez-Weldon A, Moore DR, Kotake Y (2003) Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes 52:1994-1999
44. Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13:114-119
45. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-305
46. O'Shea JJ, Ma A, Lipsky P (2002) Cytokines and autoimmunity. Nat Rev Immunol 2:37-45
47. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 87:968-972
48. Yang XD, Tisch R, Singer SM et al. (1994) Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004
49. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA (1996) Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med 184:1963-1974
50. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF (1997) TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J Immunol 159:6298-6303
51. Green EA, Flavell RA (2000) The temporal importance of TNF-alpha expression in the development of diabetes. Immunity 12:459-469
52. Christen U, Wolfe T, Mohrle U et al. (2001) A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166:7023-7032
53. Skak K, Guerder S, Picarella DE, Brenden N, Flavell RA, Michelsen BK (2003) TNF-alpha impairs peripheral tolerance towards beta-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells. Eur J Immunol 33:1341-1350
54. Parker DC, Greiner DL, Phillips NE et al. (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 92:9560-9564
55. Kover KL, Geng Z, Hess DM, Benjamin CD, Moore WV (2000) Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes 49:1666-1670
56. Phillips NE, Markees TG, Mordes JP, Greiner DL, Rossini AA (2003) Blockade of CD40-mediated signalling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol 170:3015-3023